T he stroke-prone spontaneously hypertensive rat (SHRSP) genetically has severe hypertension and cerebral stroke. 1 This strain has been thought to be a good model for cerebral hemorrhage and cerebral small vessel diseases, such as lacunar infarction and deep white matter hyperintensity, at least in some aspects of their pathology.
T he stroke-prone spontaneously hypertensive rat (SHRSP) genetically has severe hypertension and cerebral stroke. 1 This strain has been thought to be a good model for cerebral hemorrhage and cerebral small vessel diseases, such as lacunar infarction and deep white matter hyperintensity, at least in some aspects of their pathology. [2] [3] [4] [5] Accordingly, information about the genetic mechanisms underlying cerebral stroke in SHRSP may provide important clues to understand the pathogenesis of cerebrovascular diseases based on severe hypertension. [3] [4] [5] Several studies on genetic susceptibility to stroke have been performed in SHRSP; Rubattu et al 6, 7 identified quantitative trait loci (QTLs) for stroke latency on chromosomes (chr) 1, 4, and 5 using a F2 cross between SHRSP/Bbb and SHR/ Bbb, of which the QTL on chr 1 was confirmed in congenic rats. Jeffs et al 8 performed a QTL analysis on infarction volume after middle-cerebral artery occlusion using a F2 cross between SHRSP/Gcrc and WKY/Gcrc and found a QTL on chr 5. Despite these pioneering works, the genetic mechanisms behind the stroke susceptibility in SHRSP have not been clarified yet.
Here, we therefore performed a QTL analysis on stroke susceptibility in SHRSP/Izm. As a quantitative trait to evaluate stroke susceptibility, we used stroke latency under salt loading as in a previous study with a slight modification 6 ; the incidence of stroke differs greatly between SHRSP and SHR under salt loading, 1, 6 which implies that salt-sensitive mechanisms are the key to understand the susceptibility to stroke in this model.
In addition, baseline blood pressure (BP) of SHRSP/Izm differs significantly from that of SHR/Izm, which was in contrast to comparisons between SHRSP/Bbb and SHR/Bbb. 1, 6 This raises the possibility that another QTL for baseline BP would be identified when SHRSP and SHR of the Izm colony were used in the analysis.
Consequently, we performed a QTL analysis on stroke latency under salt loading, as well as on BP before and after salt loading. In this study, we successfully identified 2 major QTLs for the stroke latency in SHRSP/Izm on chr 1 and 18 and confirmed their effects in reciprocal single and double congenic strains. Furthermore, a comprehensive genotype analysis in substrains of SHRSP and SHR in the target regions
Whole Genome Sequencing
The genomes of SHRSP/Izm and SHR/Izm were sequenced using a SOLiD 4 System (Life Technologies Co., Carlsbad, CA). The coverage was ≈20× the rat genome. The sequence reads were mapped on the Rattus Norvegicus genome assembly (rn4).
Statistics
All data are represented as the mean±SD. The QTL analysis was performed with MapManager QTX version 20. 10 Statistical analyses were performed with JMP version 9 (SAS Institute Inc., Cary, NC).
Results
In the initial analysis, significant QTLs for stroke latency (a stroke-free period after the start of salt loading, see onlineonly Data Supplement Methods) and baseline BP (BP at 12 weeks of age before the start of salt loading) were identified on chr 1 and 18 ( Figure S1 ). In addition, QTLs of suggestive significance were observed on chr 5 (for stroke latency) and on chr 15 (for baseline and post-salt BP [BP after 2 weeks of salt loading]; Figures S1-S3).
Refined QTL maps were then constructed on chr 1 and 18 with markers additionally genotyped ( Figure 1A ). On chr 1, a highly significant peak for stroke latency was identified near D1Rat178 (the maximal log of odds [LOD]=8.7). Of interest, this peak overlapped with a peak for baseline BP (the maximal LOD=4.8). Post-salt BP gave a broader peak with a maximal LOD of 3.6 on chr 1. On chr 18, a broad peak for stroke latency was observed with a maximal LOD of 9.4 near D18Rat41. In contrast to chr 1, no significant QTLs were identified for either baseline or post-salt BP on chr 18.
When effects of genotype were evaluated by ANOVA at the marker nearest to the peak of each QTL, the SHRSP allele was found to have deleterious effects on stroke latency and baseline BP at the QTLs on chr 1 and 18, whereas it paradoxically showed protective effects on stroke latency and baseline/ post-salt BP at the QTLs on chr 5 and 15, respectively (Table  S2 ). The deleterious/protective effect of each allele at those QTLs was replicated in both the male and female F2 rats, although some did not reach a significant level (Table S2) . The protective effect of the SHRSP allele of chr 5 including the Nppa locus confirmed the previous observation on stroke latency ( Figure S3 ). 6 Interestingly, the QTL for post-salt BP on chr 15 includes Ephx2, a gene responsible for cardiac failure, the SHRSP allele of which conferred a protective effect ( Figure S3 ).
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On the basis of these results, we focused on the QTLs on chr 1 and 18 and constructed reciprocal congenic strains for those regions ( Figure 1B and Figure S2 ). In the phenotype analysis of the congenic strains, baseline BP measured by the tail-cuff method was significantly lower in SPrch1.0 than in SHRSP, whereas no significant decrease was found in SPrch18.0 and SPrch1_18 ( Figure 2B, top) . However, in the reciprocal congenic strains on the SHR background, no significant increase in baseline BP was observed when compared with that in SHR (Figure 2A, top) .
In contrast to baseline BP, reciprocal exchange of the chr 1 and 18 QTL regions resulted in a significant elongation and reduction of stroke latency in the SHRSP-and SHR-based congenic strains, respectively (Figure 2, bottom) . Furthermore, the double congenic strains showed much greater effects than the single congenic strains. These results indicated that the major genes for stroke latency were in these 2 congenic fragments and epistatic (inhibitory) interaction between the 2 QTLs, or between the QTLs and the background genome were not likely because clear reciprocal effects of the QTLs were observed on both the SHR and the SHRSP background.
Further analysis using the Cox proportional hazard model indicated that the risk ratio (the SHRSP homozygote/the SHR homozygote) was 8.8 for the chr 1 QTL, 5.2 for the chr 18 QTL, and 3.9 for the background genome (all 3 were significant at P<0.0001). No significant interaction was observed between the 2 QTLs (P=0.16), indicating their effects on stroke latency to be additive.
Correlations between baseline BP and stroke latency were examined in the 6 congenic strains ( Figure S4 ). Although inverse correlations were observed in the 3 SHR-based congenic strains, no correlations were significant in the SHRSPbased congenic strains. Why the correlations were not significant in the latter congenic strains is unclear, but it might be partly because SPrch1_18 had a large number of censored cases at the end of the observation period, which might make the correlation obscure, and because SPrch1.0 and 18.0 had narrow ranges of stroke latency.
BP changes during salt loading were monitored by the radio telemetry ( Figure 3 ). As BP in the dark and light phases showed similar changes (data not shown), only BP in the light phase is indicated in the figure. Baseline BP was significantly lower in the 3 SHRSP-based congenic strains than in SHRSP, but no significant increase was observed in the SHR-based congenic strains compared with that in SHR ( Figure 3C ). It was of interest that only SHRpch1_18 showed a highly significant increase in BP during the salt loading, whereas the other congenic strains showed modest or no increase (Figure 3) .
Although the QTLs on chr 1 and 18 for stroke latency were confirmed in the congenic strains, the target regions were still very broad. To narrow down the QTL regions, we attempted a comprehensive haplotype analysis using 11 substrains of substrains at many SSRs probably because these strains were separated from the other SHR substrains at an early stage before the establishment of SHRSP. On the basis of this result, we constructed 2 additional subcongenic strains for the chr 1 QTL (SPrch1.1 and 1.5; Figure 4A ). As expected, the stroke latency in SPrch1.1 did not differ significantly from that in SPrch1.0, whereas SPrch1.5 showed a significant reduction in the latency ( Figure 4C ). Baseline BP in SPrch1.1 and 1.5 was not significantly different from that in SHRSP ( Figure 4B ).
Discussion
Here, we identified fragments on chr 1 and 18 of SHRSP harboring major genes responsible for stroke susceptibility under salt loading. Analysis of the double congenic strains indicated that the 2 QTLs explained most of the stroke susceptibility in SHRSP; the combined effect of the 2 QTLs (representing 4% of the genome) on the relative risk for stroke was 10× greater than that of the background genome (by the Cox hazard model). Furthermore, through genotyping of SSR markers in the substrains, we successfully narrowed down the candidate region to a 7-Mbp fragment on chr 1.
It was of interest that the QTL for stroke latency and for baseline BP overlapped with each other on chr 1, whereas no QTLs for BP were identified on chr 18. It was thus tempting to hypothesize that the genes responsible for stroke latency on chr 1 affect the latency in a BP-dependent manner, whereas those on chr 18 were BP-independent, although there is another possibility that multiple genes in the chr 1 QTL might affect BP and stroke latency separately. In the study of congenic strains, however, the BP data did not provide any immediate support for this hypothesis; although substitution of the chr 1 QTL in SPrch1.0 resulted in a significant decrease in BP, substitution of the same fragment in SHRpch1.0, SHRpch1_18, and SPrch1_18 had no significant effect on the baseline BP measured by the tail-cuff method (Figure 2A and 2B). On the contrary, the analysis by radio telemetry indicated a significant decrease in baseline BP in all the 3 SHRSPbased congenic strains; a significant decrease was observed even in SPrch18.0 in which the chr 1 QTL was not substituted ( Figure 3C ). In contrast, no significant increase was observed in any of the 3 SHR-based congenic strains when compared with SHR ( Figure 3C ). Stress imposed on rats in the tail-cuff BP measurement might be a major cause of the discrepancy between the BP data measured by the tail-cuff method and by the telemetry. 13, 14 In any case, these observations indicate the difficulty in analyzing QTLs for BP.
The QTL on chr 1 identified in this study had some overlap with that reported by Rubattu et al. 6 However, because the smaller region defined by the study of the subcongenic SPrch1.1 did not overlap with the congenic region examined by Rubattu et al 7 ( Figure 4 ), the QTL identified in this study was unique. A slight difference in the protocol of salt loading and in the genetic background of SHRSP and SHR used in the experiments might explain the different results between the 2 studies. On the chr 1, a QTL influencing cerebral blood flow and vascular myogenic tone was identified in fawnhooded rats. 15 Although this was an interesting result in terms of pathophysiological mechanisms of stroke in SHRSP, the region was apart from that identified in the SHRSP-SHR cross in this study. Similar physiological evaluations are warranted in the congenic strains established in the present study.
Concerning the physiological mechanisms underlying the stroke susceptibility, it is of interest that SHRpch1_18 showed a clear increase in BP under salt loading, whereas the reciprocal double congenic strain, SPrch1_18, did not ( Figure 3 ). This result implied that the 2 QTLs conferred their effects on stroke latency, at least partly, through the salt-sensitive increase in BP. Recent genetic studies on Mendelian hypertensive disorders and genome-wide association studies on human hypertensives have revealed many causative or candidate genes for salt-sensitive hypertension. 16 Among them, NEDD4L was in the region syntenic to the QTL on rat chr 18. 16 Considering both the functional importance of NEDD4L in renal sodium reabsorption 17, 18 and the association of the SNPs in this gene with hypertension in humans, [19] [20] [21] Nedd4l is a strong candidate for the gene responsible in the chr 18 QTL in rats. Although the same gene was assumed to be a strong candidate for salt-dependent hypertension in Dahl saltsensitive rats (DahlSS), it was excluded by sequence and gene expression analyses. 22 Similarly, our sequence analysis of the coding region of Nedd4l in SHRSP/Izm and SHR/Izm identified only 1 synonymous nucleotide substitution (at 61 455 238 bp), with no apparent functional significance (Table S4 ). The preliminary results of our gene expression studies showed, on one hand, that the renal expression of Nedd4l after 1 week of salt loading in SHRpch1_18 elicited a modest but significant increase when compared with that in SPrch1_18 ( Figure S5 ). However, because SHRpch1_18 was more salt-sensitive than SPrch1_18 (Figure 3 ), this result seemed inconsistent with the role of Nedd4l as a negative regulator of the epithelial sodium channel. 17, 18 We additionally examined the gene expression of the 3 subunits of the epithelial sodium transporter (Scnn1a, b, and g). Although several differences in the expression levels were observed, they were rather marginal and not convincing enough to support the possible causative role of Nedd4l ( Figure S5 ). These results failed to give us direct and compelling evidence supporting the candidacy of Nedd4l for the stroke susceptibility in SHRSP. Considering the observation in the double congenic strain, SHRpch1_18 (Figure 3 ), Nedd4l (and other genes in the chr 18 QTL) may interact with the genes in the chr 1 QTL to increase BP under salt loading. This may raise the possibility of a unique genetic mechanism of salt sensitivity in SHRSP.
Chauvet et al 22 showed that Alpk2 located close to the Nedd4l locus harbored several missense mutations between DahlSS and Lewis rats, suggesting that it was the candidate gene for the salt sensitivity in DahlSS. Between SHRSP and SHR, however, no such mutations in the coding sequence of Alpk2 were identified in the present study (data not shown). Although this implies that SHRSP does not share the same causative gene with DahlSS, careful evaluation of pathological roles of Alpk2 in DahlSS would be first necessary to draw the definitive conclusion.
On the basis of the whole-genome sequence data of SHRSP/ Izm and SHR/Izm, we identified nonsynonymous variations in 25 and 8 genes located in the congenic fragments of SPrch1.1 and SPrch18.0, respectively (Table S4) . Those genes were, however, not obvious candidates from a functional point of view. Although this study substantially reduced the target region on chr 1, the sequence analysis identified >2000 single-nucleotide substitutions even if the analysis was limited to areas inside and around the putative genes (onlineonly Data Supplement Methods). Furthermore, a recent study by the ENCODE Project Consortium revealed that the intergenic regions in mammalian genomes may have more important regulatory roles than expected. 23 Intensive effort is thus required to clarify the genetic mechanisms of stroke susceptibility embedded in the congenic regions.
This study has several limitations. First, the marker density in the QTL analysis was not enough to cover the whole genome. Assuming that 1 SSR marker covers 10 cM on each side of the marker, the set of markers used in the analysis covered only half of the rat genome (≈1000 cM). Furthermore, gaps between the markers often exceeded 20 cM (Table S1 ). This was mainly because of the similarity of genetic background between SHR and SHRSP. Indeed, a recent genome analysis using ≈10 000 SNPs indicated that 86.6% of the genome was identical-by-decent between SHRB2 and SHRA3, which are substrains of SHR and SHRSP, respectively. 24 Despite the compelling evidence of the 2 major QTLs for stroke latency on chr 1 and 18, it is therefore possible that we missed QTLs hiding behind large identical-by-decent regions.
Another limitation of the present study was a lack of inference of molecular mechanisms of the QTL effects. Despite that the salt-sensitive BP increase seemed to have an important role in the stroke susceptibility, clues to understand the molecular mechanisms underlying it were not sufficient. Although Nedd4l was a strong candidate in this context (see Discussion above), our initial attempt to obtain definite genetic evidence to support this was unsuccessful. This result does not exclude Nedd4l from the candidates. A variety of molecular mechanisms, such as context-dependent modification of gene expression by epigenetic mechanisms, microRNA, promoter/ intronic/intergenic mutations, and gene-gene interactions, may influence functions of genes. 12, 23, 25 However, a series of extensive studies are essential to clarify the complex biological processes potentially involving Nedd4l and other candidate genes.
Despite the limitations outlined above, this study successfully identified 2 unique QTLs that explained a major part of the stroke susceptibility in SHRSP and suggested a potential role for the 2 QTLs in the salt-sensitive increase in BP. In addition, the double congenic strains established in this study will provide a good model to explore biological mechanisms underlying the stroke susceptibility in SHRSP. 12 Further narrowing down of the congenic regions and intensive functional analyses on the congenic strains would be required to identify the causal mutations.
Perspectives
This study identified 2 unique chromosomal fragments harboring major genes responsible for the stroke susceptibility under salt loading in SHRSP/Izm. The reciprocal double congenic strains established in this study represented most of the interstrain difference in stroke susceptibility between SHRSP and SHR, and hence will be a useful model system to explore the pathophysiological mechanisms of the stroke susceptibility and salt sensitivity in SHRSP. What Is New?
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Sources of Funding
• Two new QTLs for stroke susceptibility were identified in SHRSP, and a set of reciprocal double congenic rats was constructed accordingly.
What Is Relevant?
• The present results provide important clues to understand the genetic mechanisms of stroke susceptibility in SHRSP. In addition, the double congenic strains established will be a good model system.
Summary
Four percent of the genome on chromosomes 1 and 18 explains most of the stroke susceptibility in SHRSP, and the salt-sensitive increase in blood pressure played a major role. 
QTL analysis
Male SHRSP and female SHR were mated to obtain F1 progenies, which were then intercrossed to obtain 295 F2 rats (140 males and 155 females). Baseline BP was measured at 12 weeks of age by the tail-cuff method (BP-98A, Softron, Tokyo, Japan).
Salt-loading was then started with 1 % salt in the drinking water. BP was measured again by the tail-cuff method after two-weeks of salt-loading (post-salt BP). The rats were checked for signs of cerebral stroke once every day. When any signs of stroke were confirmed at two serial observations (paralysis, akinesia, twitch and hyper-irritability to physical stimuli), the rats were euthanized with carbon dioxide gas and the brain was dissected to check it for cerebral infarction and/or hemorrhage. The liver tissue was dissected for extraction of DNA. Days between the start of salt-loading and the first day when the signs of stroke appeared were analyzed as stroke-latency. The observation was censored at 90 days of salt-loading.
Seventy-four simple-sequence-repeat (SSR) markers polymorphic between SHRSP/Izm and SHR/Izm were genotyped in the F2 rats (Table S1 ). After the initial genome-wide analysis (Fig. S1 ), an additional 26 and 28 markers were genotyped on chr 1 and 18, respectively (Tab. S1) to construct refined QTL maps. Single-nucleotide polymorphisms (SNPs) previously identified in the Ephx2 gene (G405A) on chr 15 and in the atrial natriuretic peptide gene (Nppa) on chr 5 were genotyped using the Taqman and the mutagenically separated PCR method, respectively, as described previously (1, 2).
As two independent F2 cohorts were made to obtain phenotype data, the data were standardized in each cohort and sex when they were combined in the QTL analysis.
Stroke-latency was log-transformed before the analysis.
Construction of congenic strains
Two pairs of reciprocal congenic strains for the QTLs on chr 1 and 18 were constructed by the speed congenic strategy (3). The target regions were between D1Rat93 and Rat269, and between D18Rat73 and Rat11, respectively [ Fig. 1(B Briefly, a male SPrch1.0 was backcrossed with female SHRSP/Izm to obtain F1 rats, which were then intercrossed with one another to obtain F2 rats. Through genotyping of the F2 rats, individuals with necessary recombinations were identified and backcrossed with SHRSP/Izm to obtain male and female heterozygotes. These heterozygotes were then mated with each other to establish the homozygous subcongenic strains.
Phenotypic evaluation of the congenic strains
Male rats at 12 weeks of age were used in all the experiments. The stroke-latency under salt-loading was evaluated in the 6 congenic strains as described above for the QTL analysis. BP was measured at the start of salt-loading by the tail-cuff method.
Occurrence of stroke was confirmed by MRI examination (MRmini SA1508, 1.5T, DS Pharma Biomedical Co. Ltd., Suita, Japan) before rats were sacrificed. Follow-up was censored at 95 days after salt-loading was started.
BP under salt-loading was monitored for 4 weeks using telemetry (DSI, St. Paul, MN).
At 11 weeks of age, a telemetry transducer was implanted in the abdominal cavity under anesthesia by intraperitoneal injection of pentobarbital (50 mg/kg body weight). After 1 week of recovery, baseline BP was monitored for 1 week. Salt-loading was then started and changes in BP were observed for an additional 4 weeks. BP was measured every 10 min and the average between 11:00 and 13:00 and between 23:00 and 1:00
represented BPs in the light and dark phases, respectively.
SSR genotyping in the substrains
Three hundred and forty SSRs on chr 1 and ninety on chr 18 were selected to cover the QTL regions and were genotyped in 6 and 5 substrains of SHR and SHRSP, respectively ( Fig. 4 and Table S3 The base substitutions were named using SAMtools (version 0.1.7) (5).
Quantitative RT-PCR Male SHRpch1.0 and SPrch1.0 at 12 weeks of age were used. After one week of salt-loading, the rats were sacrificed and kidneys were dissected and snap frozen in liquid nitrogen. Total RNA was isolated using Sepasol-RNA I Super G (Nakalai, Kyoto, Japan) following the manufacturer's protocol. Complementary DNA was synthesized using a PrimeScript RT reagent Kit (Takara, Shiga, Japan) with random 6-mers.
Quantitative real-time PCR was performed on a Real-time PCR system 7300 (Applied Biosystems, Foster City, CA) in a total volume of 25 μl of reaction mixture, using SYBR Premix EX-Taq II (Takara, Shiga, Japan). The relative quantity of the mRNA was standardized using β-actin mRNA.
Sequences of the primers used in the experiments were as follows; 
Rat398 35044
Rat91 40985
Rat95 66832
Rat316 67678
Mgh5 78134
Rat23 78685
Rat177 78755
Rat261 79101
Got82 79624
Rat339 80666
Rat97 80868
Got84 81000
Wox17 81345
Rat213 81549
Rat337 82646
Rat262 83320 
Rat17 47563
Got44 47969
Got42 48443
Rat94 51753
Rat73 52291
Got55 52341
Got50 52360
Got59 58417
Rat41 59279
Rat60 60199
Rat91 61205
Rat52 61291
Rat40 62106
Got61 62531
Got64 62691
Rat89 63697
Rat87 66218
Rat43 66652
Rat13 66720
Rat14 67024
Rat124 68060
Mgh3 69013
Rat15 69404 D1Rat186  15833  1  2  2  2  1  2  2  2  2 D1Rat11  34505  1  1  1  1  1  2  3  2  2   D1Rat397  35044  1  1  1  1  1  2  2  2  2   D1Rat401  35044  1  1  1  1  1  2  2  2  2   D1Rat399  35044  1  1  3  1  1  2  2  2  2   D1Rat13  35044  1  1  3  1  1  2  2  2  2   D1Rat400  35044  1  1  3  1  1  2  2  2  2   D1Rat398  35044  1  1  3  1  1  2  2  2 The sequences of SHRSP/Izm and SHR/Izm were compared to identify single nucleotide substitutions as described in the supplementary methods. Exons, introns and 5 Kbp of 5'-untranslated regions of the genes located in the target fragments were analyzed. Table S4 . Non-synomimous single-nucleotide substitutions identified in the genes located in the target regions on chr 1 and 18. p<0.05 compared with SHRpch1_18.! Cont; without salt-loading, Salt; with salt-loading!
